Investigating the Adjunctive Use of Mirabegron in the Early Post-Rezum Procedure Period

NCT07017439 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Benign Prostate Hypertrophy(BPH)

Interventions

DRUG: Beta-3 agonists (Mirabegron/Myrbetriq)
OTHER: Placebo group post rezum

Sponsor

University of Manitoba